Abstract:Abstract Aristolochic acids (AA) are a family of structurally related nitrophenanthrene carboxylic acids, mainly consisting of aristolochic acid I (AAI) and aristolochic acid II (AAII), and are the active component of some herbal medicines. Use of dietary supplements and other botanical products containing AA have resulted in severe nephrotoxicity and consequent renal replacement therapy. Aristolochic acids are potent carcinogens as well, inducing urothelial cancers in humans and kidney tumors in rats. Previous studies have shown that the tumorigenicity of AA could result from AA-induced DNA adduct formation and mutation induction. To further understand the molecular mechanisms underlying AA-induced nephrotoxicity (e.g., carcinogenesis) and identify disease biomarkers, a quantitative proteomic analysis was conducted on kidneys from AA-treated rats. Animal treatment was conducted according to the approved protocol and followed the recommendations of the NCTR Institutional Animal Care and Use Committee. Six-week-old Big Blue rats were treated with AA as its sodium salt at concentrations of 0.1, 1.0, and 10.0 mg/kg body weight by gavage five times/week for 12 weeks or with 0.9% sodium chloride as the control using the same schedule. Six rats from each treatment group were sacrificed 1 day after the last treatment. The kidneys were isolated, frozen quickly in liquid nitrogen, and stored at −80 °C. Kidney tissues from the control and the highest AA dose treatment (10 mg/kg body weight) were selected for proteomic analysis. Proteins were extracted and digested into peptides. Trypsin-catalyzed 16O/18O stable isotope labeling was performed for each pair of control/treatment samples, which were then analyzed using two-dimensional liquid chromatography coupled online with tandem mass spectrometry (LC-MS/MS). Approximately 3000 proteins were quantified from each pair of samples, and more than 150 proteins were concordantly over expressed or under expressed across all the AA-treated samples. Pathway analysis indicated that significant changes include proteins involving xenobiotic metabolism, response to stimulus including DNA damage, cell proliferation and neoplasm, etc. Intriguingly, proteins indicating kidney pathological changes such as nephron degeneration were identified as well. Although further verification is needed, the quantitative proteomic study identified proteins related to potential toxicity and oncogenic pathways and proteins that could serve as urinary biomarkers of renal damage inflicted by aristolochic acid exposure. The views presented do not necessarily reflect those of the U. S. Food and Drug Administration. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr LB-438. doi:10.1158/1538-7445.AM2011-LB-438

Comparative Analysis of Aristolochic Acids in Aristolochia Medicinal Herbs and Evaluation of Their Toxicities

Characterization and Quantitation of Aristolochic Acid Analogs in Different Parts of Aristolochiae Fructus, Using UHPLC-Q/TOF-MS and UHPLC-QqQ-MS.

Abstract LB-438: Proteomic Analysis of Aristolochic Acid-Induced Nephrotoxicity in Rats

Kinetics of aristolochic acid I after oral administration of Radix Aristolochiae or Guanxinsuhe preparation in canines.

Analysis of Aristolochic Acids, Aristololactams and Their Analogues Using Liquid Chromatography Tandem Mass Spectrometry.

Molecular identification and cytotoxicity study of herbal medicinal materials that are confused by Aristolochia herbs

Research of Aristolochic Acid Ⅰ,Aristolochic Acid Ⅱ and Their Metabolites in Rat Liver Microsomes Using HPLC-MS/MS

Study on DNA Damage Induced by Aristolochic Acid in Vitro

Study on Rapid Determination of Aristolochic Acids in Aristolochia Medicinal Plants.

Comprehensive HRMS Screening and Risk Assessments of Aristolochic Acid Analogues in Asari Radix Et Rhizoma and Related Commercial Health Products

Recognition of the Toxicity of Aristolochic Acid

Study of the Contents of Analogues of Aristolochic Acid in Houttuynia cordata by Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry

Cytotoxicity of Phenanthrenes Extracted from <i>aristolochia Contorta</i> in Human Proximal Tubular Epithelial Cell Line

Characterization and Determination of Six Aristolochic Acids and Three Aristololactams in Medicinal Plants and Their Preparations by High-Performance Liquid Chromatography-Photodiode Array Detection/Electrospray Ionization Mass Spectrometry

Simultaneous Analysis of Six Aristolochic Acids and Five Aristolactams in Herbal Plants and Their Preparations by High-Performance Liquid Chromatography-Diode Array Detection-Fluorescence Detection

Evaluation of aristolochic acid Ι nephrotoxicity in mice via 1H NMR quantitative metabolomics and network pharmacology approaches

Comparative Study of the Contents of Analogues of Aristolochic Acid in Two Kinds of Aristolochiae Fructus by High-Performance Liquid Chromatography

Chemical Profiling of Principle Active and Toxic Constituents in Herbs Containing Aristolochic Acids

Quantitative Determination and Toxicity Evaluation of Aristolochic Acid Analogues in Asarum heterotropoides F. Schmidt (Xixin) and Traditional Chinese Patent Medicines

Differences in p38-STAT3-S100A11 signaling after the administration of aristolochic acid I and IVa may account for the disparity in their nephrotoxicity

Simultaneous Determination of Five Aristolochic Acids and Two Aristololactams in Aristolochia Plants by High-Performance Liquid Chromatography